RxDoctor Payments Data

Rubirosa Arandia

Family · Merced, CANPI 1003401035

Payments from drug & device makers

$6,994in general payments, 2019–2025

Across 158 payments — averaging $44.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$3K
  • Amgen$554
  • Bayer$550
  • Boehringer Ingelheim$490
  • GSK$483
  • AstraZeneca$465
  • plus $2K from 21 others

What the payments were for

  • Travel & lodging$2,10330%
  • Food & beverage$4,89170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,994 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban45$47,960
JardianceEmpagliflozin36$29,446
FarxigaDapagliflozin Propanediol14$14,007
XareltoRivaroxaban11$8,123
Metoprolol Succinate111$1,190
Spironolactone51$535
Atorvastatin Calcium45$506
Losartan Potassium50$367
ClopidogrelClopidogrel Bisulfate20$290
Amiodarone Hcl14$281
Metoprolol Tartrate28$220
Lisinopril65$212
Amlodipine Besylate25$173
Furosemide15$58

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$104$47,96045 claims
Boehringer IngelheimJardiance$490$29,44636 claims
AstraZenecaFarxiga$465$14,00714 claims
Johnson & JohnsonXarelto$198$8,12311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.

Other family in Merced

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →